Axon Enterprise, Inc. (NASDAQ:AXON) Insider Sells $12,966,775.92 in Stock

Axon Enterprise, Inc. (NASDAQ:AXON) insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the sale, the insider now owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. This trade represents a 12.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Axon Enterprise Stock Down 0.6 %

Shares of AXON stock traded down $3.80 during trading hours on Friday, reaching $600.76. 50,382 shares of the company’s stock were exchanged, compared to its average volume of 548,021. Axon Enterprise, Inc. has a 1 year low of $220.78 and a 1 year high of $624.84. The stock has a market cap of $45.81 billion, a PE ratio of 156.22, a PEG ratio of 15.10 and a beta of 0.94. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock’s fifty day moving average price is $433.89 and its two-hundred day moving average price is $355.28.

Analyst Ratings Changes

Several analysts recently weighed in on AXON shares. Robert W. Baird lifted their price objective on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a report on Monday, November 4th. The Goldman Sachs Group lifted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Northland Securities lifted their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday. Needham & Company LLC lifted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Finally, JMP Securities lifted their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average target price of $427.83.

Institutional Investors Weigh In On Axon Enterprise

Large investors have recently modified their holdings of the business. Quent Capital LLC grew its stake in shares of Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after acquiring an additional 75 shares during the last quarter. Blue Trust Inc. boosted its position in Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after buying an additional 79 shares during the last quarter. Brooklyn Investment Group purchased a new stake in Axon Enterprise in the third quarter valued at approximately $41,000. Planning Capital Management Corp boosted its position in Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after buying an additional 55 shares during the last quarter. Finally, Friedenthal Financial purchased a new stake in Axon Enterprise in the third quarter valued at approximately $51,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.